Table 4.
Comparison of the Improvement of Each Index Before and After Treatment Between Observation Group and Control Group, Single Allergic Group and Multiple Allergic Group
| Variable | Observation Group vs Control Group | Single Allergic Group vs Multiple Allergic Group | ||||
|---|---|---|---|---|---|---|
| Observation Group n=100 | Control Group n=100 | P | Single Allergic Group n=26 | Multiple Allergic Group n=74 | P | |
| C-ACT | 8.0 (6.0,12.0) | 7.0 (4.0,9.0) | 0.001 | 8.0 (6.5,12.5) | 8.5 (6.0,12.0) | 0.960 |
| VAS score | −3.0 (−5.0,-1.0) | −2.0 (−4.0,-1.0) | 0.019 | −3.5 (−4.0,-1.5) | −3.0 (−5.0,-1.0) | 0.806 |
| Drug score | −3.0 (−4.0,-2.0) | −1.0 (−1.0,0.0) | <0.001 | −3.0 (−4.0,-2.0) | −3.0 (−4.0,-2.0) | 0.784 |
| FVC | 12.4 (4.3,19.7) | 6.6 (1.1,11.1) | <0.001 | 14.3 (1.8,26.2) | 11.9 (4.6,17.8) | 0.716 |
| FEV1 | 15.4 (4.2,24.8) | 7.2 (2.1,12.6) | 0.001 | 20.8 (10.2,31.6) | 12.9 (4.0,22.3) | 0.042 |
| PEF | 12.4 (2.8,22.0) | 9.5 (4.0,17.0) | 0.256 | 13.9±14.6 | 11.2±17.2 | 0.523a |
| PEF75 | 23.4 (6.1,45.3) | 12.0 (4.8,21.9) | 0.002 | 28.1±31.1 | 25.5±30.4 | 0.734a |
| PEF50 | 17.8 (5.1,35.1) | 7.9 (−0.6,21.5) | 0.001 | 22.9 (5.9,47.4) | 17.7 (5.7,33.3) | 0.376 |
| PEF25 | 23.2 (6.7,37.1) | 8.6 (−0.2,15.6) | <0.001 | 22.2 (2.1,47.6) | 23.2 (7.1,35.2) | 0.724 |
| MMEF75/MMEF25 | 17.8 (8.2,33.1) | 9.8 (4.9,16.8) | 0.004 | 18.3 (−2.0,48.7) | 17.5 (9.2,28.7) | 0.819 |
| FeNO | −13.5 (−21.5,-7.0) | −9.0 (−22.0,-2.0) | 0.039 | −15.5 (−24.5,-9.0) | −13.0 (−20.5,-7.0) | 0.654 |
Note: astudent’t-test. Mann-Whitney U-test is used for the rest.